Disease modifying therapies in multiple sclerosis: Could a baseline thyroid check-up drive the therapeutic choice between interferon-β and glatiramer acetate?

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)1918-1919
Number of pages2
JournalMultiple Sclerosis Journal
Issue number14
Publication statusPublished - Dec 16 2014

ASJC Scopus subject areas

  • Clinical Neurology
  • Neurology

Cite this